BOSTON PARTNERS INVESTMENT FUNDS
|
||||||
BOSTON PARTNERS ALL-CAP VALUE FUND
|
||||||
PORTFOLIO OF INVESTMENTS
|
||||||
MAY 31, 2020 (UNAUDITED)
|
NUMBER OF
|
||||||||
SHARES
|
VALUE
|
|||||||
COMMON STOCKS—96.4%
|
||||||||
Communication Services—5.2%
|
||||||||
Activision Blizzard, Inc.
|
95,612
|
$
|
6,882,152
|
|||||
Alphabet, Inc., Class A*
|
6,769
|
9,703,497
|
||||||
Comcast Corp., Class A
|
181,244
|
7,177,262
|
||||||
Electronic Arts, Inc.*
|
30,893
|
3,796,132
|
||||||
Facebook, Inc., Class A*
|
33,521
|
7,545,242
|
||||||
Fox Corp., Class A(a)
|
368,333
|
10,744,274
|
||||||
Interpublic Group of Cos., Inc., (The)
|
490,839
|
8,398,255
|
||||||
Momo, Inc. - SP ADR
|
168,661
|
3,272,023
|
||||||
NetEase, Inc. - ADR
|
19,428
|
7,438,981
|
||||||
Omnicom Group, Inc.(a)
|
64,748
|
3,547,543
|
||||||
68,505,361
|
||||||||
Consumer Discretionary—8.2%
|
||||||||
AutoZone, Inc.*
|
7,037
|
8,077,491
|
||||||
eBay, Inc.(a)
|
329,833
|
15,020,595
|
||||||
Fiat Chrysler Automobiles NV
|
195,041
|
1,724,162
|
||||||
Foot Locker, Inc.(a)
|
311,613
|
8,631,680
|
||||||
Gentex Corp.
|
99,337
|
2,626,470
|
||||||
International Game Technology PLC(a)
|
472,874
|
3,986,328
|
||||||
Las Vegas Sands Corp.*
|
74,043
|
3,549,621
|
||||||
Lear Corp.*
|
51,620
|
5,474,301
|
||||||
Lowe's Cos., Inc.
|
109,362
|
14,255,337
|
||||||
Magna International, Inc.
|
69,359
|
2,925,563
|
||||||
Melco Resorts & Entertainment Ltd. - ADR*
|
321,939
|
5,160,682
|
||||||
Mohawk Industries, Inc.*(a)
|
63,094
|
5,880,361
|
||||||
NVR, Inc.*
|
2,307
|
7,432,254
|
||||||
Target Corp.
|
56,885
|
6,958,742
|
||||||
Whirlpool Corp.(a)
|
70,940
|
8,641,911
|
||||||
Wyndham Destinations, Inc.
|
94,952
|
3,019,473
|
||||||
Wyndham Hotels & Resorts, Inc.(a)
|
82,877
|
3,806,541
|
||||||
107,171,512
|
||||||||
Consumer Staples—1.4%
|
||||||||
Altria Group, Inc.
|
126,282
|
4,931,312
|
||||||
Ambev SA - ADR
|
1,365,489
|
3,154,280
|
||||||
Nomad Foods Ltd.*
|
178,769
|
3,786,327
|
||||||
Philip Morris International, Inc.
|
94,593
|
6,939,343
|
||||||
18,811,262
|
||||||||
Energy—2.3%
|
||||||||
Apergy Corp.*(a)
|
141,421
|
1,282,689
|
||||||
Canadian Natural Resources Ltd.(a)
|
259,020
|
4,688,262
|
||||||
Cimarex Energy Co.
|
166,744
|
4,382,032
|
||||||
Diamondback Energy, Inc.(a)
|
152,087
|
6,475,864
|
||||||
Marathon Oil Corp.*
|
810,380
|
4,327,429
|
||||||
Phillips 66
|
72,747
|
5,693,180
|
||||||
World Fuel Services Corp.
|
124,312
|
3,167,470
|
||||||
30,016,926
|
||||||||
Financials—22.1%
|
||||||||
Aflac, Inc.
|
294,995
|
10,758,468
|
||||||
Alleghany Corp.
|
22,976
|
11,788,986
|
||||||
Allstate Corp., (The)
|
163,220
|
15,964,548
|
||||||
American International Group, Inc.(a)
|
546,882
|
16,439,273
|
||||||
Aon Plc
|
41,850
|
8,242,358
|
||||||
Bank of America Corp.
|
1,076,495
|
25,965,059
|
||||||
Charles Schwab Corp., (The)(a)
|
177,661
|
6,379,807
|
||||||
Chubb Ltd.
|
102,031
|
12,441,660
|
||||||
Citigroup, Inc.
|
403,025
|
19,308,928
|
||||||
Discover Financial Services
|
109,239
|
5,189,945
|
||||||
Fifth Third Bancorp
|
241,457
|
4,681,851
|
||||||
Globe Life, Inc.
|
49,563
|
3,817,342
|
||||||
Goldman Sachs Group, Inc., (The)
|
69,026
|
13,562,919
|
||||||
Huntington Bancshares, Inc.(a)
|
766,117
|
6,810,780
|
||||||
JPMorgan Chase & Co.
|
255,611
|
24,873,506
|
||||||
KeyCorp
|
1,132,402
|
13,418,964
|
||||||
Loews Corp.(a)
|
309,200
|
10,277,808
|
||||||
Markel Corp.*(a)
|
6,710
|
6,021,688
|
||||||
Renaissance Holdings Ltd.
|
55,827
|
9,371,120
|
||||||
State Street Corp.(a)
|
63,313
|
3,859,560
|
||||||
Synchrony Financial(a)
|
240,814
|
4,905,381
|
||||||
TD Ameritrade Holding Corp.
|
308,609
|
11,501,857
|
||||||
Travelers Cos., Inc., (The)
|
79,267
|
8,479,984
|
||||||
Truist Financial Corp.
|
328,842
|
12,094,809
|
||||||
Wells Fargo & Co.
|
393,434
|
10,414,198
|
||||||
White Mountains Insurance Group Ltd.
|
14,902
|
13,643,675
|
||||||
290,214,474
|
||||||||
Health Care—26.3%
|
||||||||
Abbott Laboratories
|
180,022
|
17,087,688
|
||||||
Alcon, Inc.*(a)
|
67,501
|
4,289,014
|
||||||
AmerisourceBergen Corp.
|
113,029
|
10,776,185
|
||||||
Anthem, Inc.
|
61,062
|
17,958,945
|
||||||
Avantor, Inc.*(a)
|
569,050
|
10,794,878
|
||||||
Biogen, Inc.*
|
47,819
|
14,684,737
|
||||||
Centene Corp.*
|
301,216
|
19,955,560
|
||||||
Change Healthcare, Inc.*
|
359,739
|
4,489,543
|
||||||
Cigna Corp.
|
44,951
|
8,869,731
|
||||||
Elanco Animal Health, Inc.*(a)
|
42,091
|
901,168
|
||||||
GlaxoSmithKline PLC - SP ADR(a)
|
180,837
|
7,580,687
|
||||||
Henry Schein, Inc.*(a)
|
116,219
|
7,056,818
|
||||||
Humana, Inc.
|
26,195
|
10,756,977
|
||||||
Jazz Pharmaceuticals PLC*
|
49,417
|
5,896,436
|
||||||
Johnson & Johnson
|
183,891
|
27,353,786
|
||||||
Laboratory Corp. of America Holdings*
|
41,960
|
7,356,427
|
||||||
McKesson Corp.
|
119,851
|
19,016,758
|
||||||
Medtronic PLC
|
259,485
|
25,580,031
|
||||||
Merck & Co., Inc.
|
198,747
|
16,042,858
|
||||||
Molina Healthcare, Inc.*
|
35,768
|
6,646,410
|
||||||
Novartis AG - SP ADR
|
267,143
|
23,356,312
|
||||||
Pfizer, Inc.
|
748,509
|
28,585,559
|
||||||
Roche Holding AG - SP ADR
|
219,774
|
9,527,203
|
||||||
Stryker Corp.
|
33,594
|
6,575,354
|
||||||
UnitedHealth Group, Inc.
|
66,323
|
20,218,567
|
||||||
Zimmer Biomet Holdings, Inc.
|
111,179
|
14,046,355
|
||||||
345,403,987
|
||||||||
Industrials—12.5%
|
||||||||
AIR LEASE Corp.(a)
|
246,422
|
7,419,766
|
||||||
Altra Industrial Motion Corp.
|
95,994
|
2,975,814
|
||||||
AMETEK, Inc.
|
84,018
|
7,705,291
|
||||||
Carrier Global Corp.*
|
63,756
|
1,305,085
|
||||||
Caterpillar, Inc.
|
55,230
|
6,634,780
|
||||||
CH Robinson Worldwide, Inc.(a)
|
53,159
|
4,312,790
|
||||||
Cummins, Inc.
|
38,032
|
6,450,227
|
||||||
Deere & Co.
|
45,122
|
6,863,959
|
||||||
Dover Corp.
|
104,721
|
10,184,117
|
||||||
Eaton Corp. PLC
|
145,045
|
12,314,321
|
||||||
EnerSys
|
69,076
|
4,372,511
|
||||||
Expeditors International of Washington, Inc.(a)
|
104,226
|
7,959,740
|
||||||
General Dynamics Corp.
|
54,411
|
7,989,167
|
||||||
Honeywell International, Inc.
|
28,786
|
4,198,438
|
||||||
Huntington Ingalls Industries, Inc.
|
34,384
|
6,873,018
|
||||||
Huron Consulting Group, Inc.*
|
57,036
|
2,638,485
|
||||||
KAR Auction Services, Inc.*
|
74,595
|
1,070,438
|
||||||
Landstar System, Inc.(a)
|
41,907
|
4,872,108
|
||||||
ManpowerGroup, Inc.(a)
|
48,816
|
3,375,138
|
||||||
Masco Corp.
|
159,586
|
7,444,687
|
||||||
Oshkosh Corp.
|
50,547
|
3,630,286
|
||||||
Otis Worldwide Corp.
|
31,879
|
1,678,429
|
||||||
Owens Corning
|
113,053
|
5,935,282
|
||||||
PACCAR, Inc.
|
106,081
|
7,835,143
|
||||||
Raytheon Technologies Corp.
|
67,765
|
4,372,198
|
||||||
Robert Half International, Inc.(a)
|
87,204
|
4,424,731
|
||||||
Spirit AeroSystems Holdings, Inc., Class A
|
197,503
|
4,279,890
|
||||||
Textron, Inc.
|
146,446
|
4,535,433
|
||||||
United Parcel Service, Inc., Class B(a)
|
71,720
|
7,151,201
|
||||||
WESCO International, Inc.*
|
80,788
|
2,690,240
|
||||||
163,492,713
|
||||||||
Information Technology—12.9%
|
||||||||
Amdocs Ltd.
|
73,917
|
4,602,073
|
||||||
Analog Devices, Inc.
|
41,185
|
4,651,846
|
||||||
Arrow Electronics, Inc.*
|
89,379
|
6,174,301
|
||||||
Belden, Inc.
|
75,192
|
2,559,536
|
||||||
CDK Global, Inc.
|
95,759
|
3,764,286
|
||||||
Cisco Systems, Inc.
|
318,343
|
15,223,162
|
||||||
Cognizant Technology Solutions Corp., Class A
|
206,591
|
10,949,323
|
||||||
Fidelity National Information Services, Inc.(a)
|
78,135
|
10,847,482
|
||||||
Flex Ltd.*
|
571,769
|
5,551,877
|
||||||
Hewlett Packard Enterprise Co.
|
413,167
|
4,011,852
|
||||||
Jabil, Inc.(a)
|
307,461
|
9,199,233
|
||||||
Leidos Holdings, Inc.
|
100,618
|
10,594,069
|
||||||
Microsoft Corp.
|
19,294
|
3,535,626
|
||||||
Oracle Corp.
|
357,343
|
19,214,333
|
||||||
Qorvo, Inc.*
|
204,768
|
21,447,400
|
||||||
Science Applications International Corp.
|
122,131
|
10,752,413
|
||||||
SS&C Technologies Holdings, Inc.(a)
|
178,703
|
10,346,010
|
||||||
TE Connectivity Ltd.
|
169,206
|
13,747,988
|
||||||
Western Digital Corp.*(a)
|
62,808
|
2,786,791
|
||||||
169,959,601
|
||||||||
Materials—4.9%
|
||||||||
Cemex SAB de CV - SP ADR(a)
|
750,918
|
1,802,203
|
||||||
Corteva, Inc.
|
507,525
|
13,860,508
|
||||||
CRH PLC - SP ADR
|
211,333
|
6,796,469
|
||||||
DuPont de Nemours, Inc.
|
212,909
|
10,800,874
|
||||||
FMC Corp.
|
142,769
|
14,049,897
|
||||||
Ingevity Corp.*
|
67,529
|
3,556,752
|
||||||
Mosaic Co., (The)
|
299,614
|
3,622,333
|
||||||
PPG Industries, Inc.
|
42,550
|
4,326,059
|
||||||
Trinseo SA
|
73,743
|
1,517,631
|
||||||
Valvoline, Inc.
|
254,785
|
4,675,305
|
||||||
65,008,031
|
||||||||
Utilities—0.6%
|
||||||||
Vistra Energy Corp.
|
357,312
|
7,303,457
|
||||||
TOTAL COMMON STOCKS
|
||||||||
(Cost $1,080,401,483)
|
1,265,887,324
|
|||||||
RIGHTS—0.0%
|
||||||||
Information Technology—0.0%
|
||||||||
CVR Banctec Inc. - Escrow Shares*‡
|
14,327
|
0
|
||||||
TOTAL RIGHTS
|
||||||||
(Cost $0)
|
0
|
|||||||
INVESTMENTS PURCHASED WITH PROCEEDS FROM SECURITIES LENDING COLLATERAL—11.7%
|
||||||||
Mount Vernon Liquid Assets Portfolio, LLC, 0.33%(b)
|
153,438,683
|
153,438,683
|
||||||
TOTAL INVESTMENTS PURCHASED WITH PROCEEDS FROM SECURITIES LENDING COLLATERAL
|
||||||||
(Cost $153,438,683)
|
153,438,683
|
|||||||
SHORT-TERM INVESTMENTS—3.5%
|
||||||||
U.S. Bank Money Market Deposit Account, 0.13%*(b)
|
45,478,732
|
45,478,732
|
||||||
TOTAL SHORT-TERM INVESTMENTS
|
||||||||
(Cost $45,478,732)
|
45,478,732
|
|||||||
TOTAL INVESTMENTS—111.6%
|
||||||||
(Cost $1,279,318,898)
|
1,464,804,739
|
|||||||
LIABILITIES IN EXCESS OF OTHER ASSETS—(11.6)%
|
(152,152,786
|
)
|
||||||
NET ASSETS—100.0%
|
$
|
1,312,651,953
|
ADR
|
American Depositary Receipt
|
|||||
PLC
|
Public Limited Company
|
|||||
SP ADR
|
Sponsored American Depositary Receipt
|
|||||
*
|
Non-income producing.
|
|||||
(a)
|
All or a portion of the security is on loan. At May 31, 2020, the market value of securities on loan was $208,322,277.
|
|||||
(b)
|
The rate shown is as of May 31, 2020.
|
|||||
‡
|
Security has been valued at fair market value using significant unobservable inputs as determined in good faith by or under the
direction of The RBB Fund, Inc.’s Board of Directors. as of May 31, 2020, these securities amounted to $0 or 0.0% of net assets.
|
BOSTON PARTNERS INVESTMENT FUNDS
|
|||||
BOSTON PARTNERS ALL-CAP VALUE FUND
|
|||||
NOTES TO PORTFOLIO OF INVESTMENTS
|
|||||
MAY 31, 2020 (UNAUDITED)
|
|||||
PORTFOLIO VALUATION — The Boston Partners All-Cap Value Fund's (the "Fund") net asset value (“NAV”) is calculated once daily at the
close of regular trading hours on the New York Stock Exchange (“NYSE”) (generally 4:00 p.m. Eastern time) on each day the NYSE is open. Securities held by the Fund are valued using the closing price or the last sale price on a national
securities exchange or the National Association of Securities Dealers Automatic Quotation System (“NASDAQ”) market system where they are primarily traded. Equity securities traded in the over-the-counter ("OTC") market are valued at their
closing prices. If there were no transactions on that day, securities traded principally on an exchange or on NASDAQ will be valued at the mean of the last bid and ask prices prior to the market close. Fixed income securities are valued
using an independent pricing service, which considers such factors as security prices, yields, maturities and ratings, and are deemed representative of market values at the close of the market. Foreign securities are valued based on prices
from the primary market in which they are traded, and are translated from the local currency into U.S. dollars using current exchange rates. Investments in other open-end investment companies, if any, are valued based on the NAV of the
investment companies (which may use fair value pricing as disclosed in their prospectuses). Options for which the primary market is a national securities exchange are valued at the last sale price on the exchange on which they are traded,
or, in the absence of any sale, will be valued at the mean of the last bid and ask prices prior to the market close. Options not traded on a national securities exchange are valued at the last quoted bid price for long option positions and
the closing ask price for short option positions. If market quotations are unavailable or deemed unreliable, securities will be valued in accordance with procedures adopted by the Company’s Board of Directors (the “Board”). Relying on
prices supplied by pricing services or dealers or using fair valuation may result in values that are higher or lower than the values used by other investment companies and investors to price the same investments. Such procedures use
fundamental valuation methods, which may include, but are not limited to, an analysis of the effect of any restrictions on the resale of the security, industry analysis and trends, significant changes in the issuer’s financial position, and
any other event which could have a significant impact on the value of the security. Determination of fair value involves subjective judgment as the actual market value of a particular security can be established only by negotiations between
the parties in a sales transaction, and the difference between the recorded fair value and the value that would be received in a sale could be significant. The Fund may use fair value pricing more frequently for securities traded primarily
in non-U.S. markets because, among other things, most foreign markets close well before the Fund values its securities, generally as of 4:00 p.m. Eastern time. The earlier close of these foreign markets gives rise to the possibility that
significant events, including broad market moves, government actions or pronouncements, aftermarket trading, or news events may have occurred in the interim. To account for this, the Fund may value foreign securities using fair value
prices based on third-party vendor modeling tools (international fair value pricing).
|
FAIR VALUE MEASUREMENTS — The
inputs and valuation techniques used to measure fair value of the Fund’s investments are summarized into three levels as described in the hierarchy below:
|
|||||
|
|||||
• Level 1 — Prices are determined using quoted prices in active markets for identical securities.
|
|||||
• Level 2 — Prices are determined using other significant observable inputs (including quoted prices for similar securities,
interest rates, prepayment speeds, credit risk, etc.).
|
|||||
• Level 3 — Prices are determined using significant unobservable inputs (including the Fund’s own assumptions in determining the
fair value of investments).
|
|||||
The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in
those securities.
|
|||||
The following is a summary of the inputs used, as of May 31, 2020, in valuing the Fund's investments carried at fair value:
|
TOTAL
|
LEVEL 1
|
LEVEL 2
|
LEVEL 3
|
INVESTMENTS MEASURED AT
NET ASSET
VALUE*
|
||||||||||||||||
Common Stock
|
||||||||||||||||||||
Communication Services
|
$
|
68,505,361
|
$
|
68,505,361
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||||
Consumer Discretionary
|
107,171,512
|
107,171,512
|
-
|
-
|
-
|
|||||||||||||||
Consumer Staples
|
18,811,262
|
18,811,262
|
-
|
-
|
-
|
|||||||||||||||
Energy
|
30,016,926
|
30,016,926
|
-
|
-
|
-
|
|||||||||||||||
Financials
|
290,214,474
|
290,214,474
|
-
|
-
|
-
|
|||||||||||||||
Health Care
|
345,403,987
|
345,403,987
|
-
|
-
|
-
|
|||||||||||||||
Industrials
|
163,492,713
|
163,492,713
|
-
|
-
|
-
|
|||||||||||||||
Information Technology
|
169,959,601
|
169,959,601
|
-
|
-
|
-
|
|||||||||||||||
Materials
|
65,008,031
|
65,008,031
|
-
|
-
|
-
|
|||||||||||||||
Utilities
|
7,303,457
|
7,303,457
|
-
|
-
|
-
|
|||||||||||||||
Rights
|
-
|
-
|
-
|
-
|
**
|
-
|
||||||||||||||
Investments Purchased with Proceeds from Securities Lending Collateral
|
153,438,683
|
-
|
-
|
-
|
153,438,683
|
|||||||||||||||
Short-Term Investments
|
45,478,732
|
45,478,732
|
-
|
-
|
-
|
|||||||||||||||
Total Assets
|
$
|
1,464,804,739
|
$
|
1,311,366,056
|
$
|
-
|
$
|
-
|
**
|
$
|
153,438,683
|
*Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient
have not been categorized in the fair value hierarchy included to reconcile to the amounts presented in the Portfolio of Investments.
|
|||||
** Value equals zero as of the end of the reporting period.
|
|||||
At the end of each quarter, management evaluates the classification of Levels 1, 2 and 3 assets and liabilities. Various factors are
considered, such as changes in liquidity from the prior reporting period; whether or not a broker is willing to execute at the quoted price; the depth and consistency of prices from third party pricing services; and the existence of
contemporaneous, observable trades in the market. Additionally, management evaluates the classification of Level 1, 2 and 3 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
|
|||||
|
|||||
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the
fair value of the Fund’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may
differ materially from the values the Fund may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
|
|||||
|
|||||
For fair valuations using significant unobservable inputs, U.S. generally accepted accounting principles (“U.S. GAAP”) requires the
Fund to present a reconciliation of the beginning to ending balances for reported market values that presents changes attributable to total realized and unrealized gains or losses, purchase and sales, and transfers in and out of Level 3
during the period. Transfers in and out between levels are based on values at the end of the period. A reconciliation of Level 3 investments is presented only when the Fund had an amount of Level 3 investments at the end of the reporting
period that was meaningful in relation to its net assets. The amounts and reasons for all Level 3 transfers are disclosed if the Fund had an amount of total Level 3 transfers during the reporting period that was meaningful in relation to
its net assets as of the end of the reporting period.
|
|||||
|
|||||
During the current fiscal year, the Fund had no significant level 3 investments or transfers.
|
|||||
For more information with regard to significant accounting policies, see the most recent semi-annual or annual report filed with the
Securities and Exchange Commission.
|
|||||
|